The COVID-19 pandemic has accelerated the transformation of business models in the life sciences industry, with digital initiatives...
A Fresh Take
Insights on M&A, litigation, and corporate governance in the US.
The M&A bull run that began in Q3 2020 shows no signs of slowing, with deal activity through the first three months of 2021 breaking the...
With the festive season approaching, we thought this a good opportunity to look back at what happened in the world of M&A in 2020 – and...
On November 11, 2020, the UK government published the National Security and Investment Bill (the “NSI Bill”), which, when enacted into...
The impact of COVID-19 on M&A activity in global markets has predictably had knock-on effects on global R&W insurance markets with deal...
As previously predicted in our blog piece Do I have to go through with this? A summary of recently filed MAE/MAC cases, material adverse...
We thought it might be helpful if we summarize the recent cases filed in the Delaware courts that implicate material adverse...
Against the backdrop of unexpected developments arising from the COVID-19 pandemic, parties with signed, but not yet closed, M&A...
A warning to potential acquirors of distressed targets appears at the end of the Delaware Court of Chancery’s recent opinion in In re...
As the economy continues to experience daily turmoil in the wake of the COVID-19 crisis, it becomes increasingly likely that some...
In the current environment, as companies fear scarcity of capital and rush to draw on their existing credit lines, they should consider...
For the vast majority of us, the speed and scope of the coronavirus pandemic came as a surprise. Only weeks ago, everything seemed...